Magnetic Resonance Imaging of Breast Cancer
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 21 Years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: MRI scans
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study compares MRI, which uses magnets to make pictures inside the body, with other imaging tests to see which best finds and shows breast cancer. It is for women with breast changes that may be cancer, including some women who have had breast cancer surgery.
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Female.
- Have a recorded breast exam.
- Have a recorded mammogram (breast X-ray) within 3 months of the MRI.
- Have a breast lump or a change seen on a mammogram that may be cancer.
- Women who have had a lumpectomy (surgery to remove breast cancer) and changes after a biopsy or radiation may qualify if a new breast concern needs a needle or surgical biopsy (a tissue sample).
Who can't join
- Male at birth.
- Have a pacemaker, metal implant, aneurysm clip (a clip on a blood vessel), or another condition that makes being near a strong magnet unsafe.
- Have a severe fear of tight or closed spaces.
- Are pregnant or breastfeeding.
- Had an MRI with contrast dye within 48 hours, or iodine-based contrast dye within 6 hours.
- Have a known reaction to MRI contrast dye.
- Are unlikely to finish the whole study.
- Have another medical reason that prevents taking part.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
INCLUSION CRITERIA * Female * Documented breast physical examination, * Documented mammography within 3 months of the MR studies * Palpable or mammographically-detected suspect breast lesions * Women who have already undergone lumpectomy for breast cancer and have post-biopsy/post-radiation changes will be eligible if they have mammographically-detected or palpable breast abnormalities which are sufficiently suspicious to merit core needle or surgical biopsy. EXCLUSION CRITERIA: * Male by birth * Able to complete the MR examination. Subjects will be interviewed by one of the investigators for the usual contraindications to * MR contraindications including * Pacemakers * Metallic implants * Severe claustrophobia * Aneurysm clips * Pregnancy * Current lactation * Other conditions precluding proximity to a strong magnetic field. * Received an enhanced MR procedure within 48 hours, * Iodinated contrast within six hours, * Known sensitivity to MR contrast agents, * Not likely to complete the study in full or * Other clinical reason which would preclude participation in the protocol.
Study sites (1)
CA
- Stanford University School of Medicine · Stanford, CA 94305Jocelyn Steffen · Study contact · 650-725-1812 · jsteffen@stanford.eduBruce Lewis Daniel · Principal investigatorBrian Andrew Hargreaves · Sub-investigatorRobert J Herfkens · Sub-investigatorMore trials in Stanford